[Leu5]-Enkephalin, amide

[Leu5]-Enkephalin, amide is a synthetic pentapeptide that closely mimics the endogenous opioid peptide leucine-enkephalin, featuring an amidated C-terminus for enhanced biochemical stability. As a member of the enkephalin peptide family, it plays a significant role in opioid receptor research, particularly due to its high affinity for delta and mu opioid receptors. Its structure and properties make it a valuable tool in neurobiological studies, signal transduction research, and investigations into pain modulation pathways. The amidation of the C-terminal residue further increases its resistance to enzymatic degradation, allowing for more reliable and reproducible results in experimental systems.

Receptor binding studies: [Leu5]-Enkephalin, amide is widely utilized in receptor pharmacology to characterize the binding properties and selectivity of opioid receptors. By serving as a reference ligand in radioligand binding assays or competitive displacement experiments, it enables researchers to quantify receptor affinity, assess binding kinetics, and distinguish between receptor subtypes. Its use is essential in elucidating the molecular mechanisms underlying opioid receptor activation and in screening novel receptor modulators or antagonists.

Signal transduction research: In cellular and biochemical assays, this peptide is employed to probe downstream signaling pathways activated by opioid receptors. Upon binding to its targets, it triggers G-protein coupled receptor (GPCR) cascades, leading to modulation of second messengers such as cAMP or intracellular calcium. Researchers leverage [Leu5]-Enkephalin, amide to dissect the temporal and spatial dynamics of opioid signaling, investigate receptor desensitization or internalization, and study cross-talk with other neurotransmitter systems.

Peptide structure-activity relationship (SAR) analysis: The analog provides a robust platform for structure-activity relationship studies, allowing systematic evaluation of modifications at the peptide backbone or side chains. By comparing the biological activity of [Leu5]-Enkephalin, amide with other enkephalin analogs, scientists can identify key residues responsible for receptor selectivity, potency, and metabolic stability. Such insights are instrumental in guiding the rational design of next-generation peptide ligands with tailored pharmacological profiles.

Peptide degradation and stability assays: The amidated form of Leu-enkephalin serves as a model substrate in studies of peptide metabolism, enzymatic degradation, and protease specificity. Researchers utilize it to assess the impact of C-terminal amidation on resistance to peptidases and to develop analytical methods for monitoring peptide half-life in various biological matrices. These investigations support the optimization of peptide-based probes and therapeutic candidates by enhancing their in vitro and in vivo stability.

Neurochemical pathway mapping: Due to its functional mimicry of endogenous opioid peptides, [Leu5]-Enkephalin, amide is instrumental in mapping neural circuits and neurotransmitter systems involved in pain perception, reward, and stress responses. By applying the peptide in ex vivo brain slice preparations, primary neuronal cultures, or in vivo microinjection protocols, scientists can delineate the physiological roles of opioid peptides, characterize synaptic modulation, and identify novel targets for neuropharmacological intervention.

1. Tachykinin-related peptides modulate immune-gene expression in the mealworm beetle Tenebrio molitor L

2. Characterization of Novel P-Selectin Targeted Complement Inhibitors in Murine Models of Hindlimb Injury and Transplantation

3. Cell-based adhesion assays for isolation of snake venom’s integrin antagonists

4. Oleic acid and glucose regulate glucagon-like peptide 1 receptor expression in a rat pancreatic ductal cell line

5. A possible role of tachykinin-related peptide on an immune system activity of mealworm beetle, Tenebrio molitor L